☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
innovent
Innovent Reports the NMPA’s NDA Acceptance of Mazdutide to Treat Type 2 Diabetes
August 1, 2024
PharmaShots Weekly Snapshots (July 22 – July 26, 2024)
July 26, 2024
Innovent Reports Data from the P-III (DREAMS-1) Study of Mazdutide to Treat Type 2 Diabetes in Chinese Patients
July 22, 2024
Innovent’s IBI343 Gains the US FDA’s Fast Track Designation to Treat Pancreatic Cancer
June 13, 2024
Innovent Reports the P-III (CLEAR-1) Study Data of Picankibart for Treating Plaque Psoriasis in Chinese Patients
May 28, 2024
Innovent Reports the NMPA’s NDA Acceptance of IBI311 for Treating Thyroid Eye Disease
May 21, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.